Stephen D. Griffin

Director, President and CEO · 1 filing · Latest: Mar 14, 2026

Anika Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ANIK	Stephen D. Griffin	Director, President and CEO	Mar 14, 2026	Option Exercise	—	12,824	—	23,495	—